ARTICLE
Auteur(s) : Kazimierz
Pasternak1, W Dąbrowski2,
J Dobija1, J Wrońska1, Z Rzecki2,
J Biernacka2
1Department of General Chemistry
2Department of Anaesthesiology and Intensive Therapy
Feliks Skubiszewski Medical University of Lublin, Poland
Electrolyte disorders and their relationship with hormonal balance
are one of the main subjects of clinical investigations [1, 2]. In
some cases this problem is important, e.g. particularly in
haemodynamically unstable patients undergoing surgical myocardial
revascularization. The complex character of extracorporeal
circulation (ECC) as well as the intraoperative therapy used may
affect electrolyte and hormonal balance and lead to its disorders.
Among them are disorders of blood magnesium concentration.It is
well known that magnesium (Mg) plays a significant role in cell
physiology and its deficiency may cause many disorders which often
require intensive treatment. The physiological level of Mg in blood
serum ranges from 0.8 to 1.2 mmol/L – 24 % combined with
proteins, 10 % in complexes and 65 % in the ionized form.
It is worth stressing that even the smallest changes in Mg
concentration in blood serum are reflected in its intracellular
level, which, in turn, affects cellular function [3]. Moreover,
even temporary or secondary deficiency of this element is likely to
lead to significant clinical dysfunction of various organs and
aggravate or alter the clinical picture of any underlying disease.
Therefore, many researchers underline the role of normomagnesemia,
especially in patients with myocardial pathology [4, 5].
Dysfunction of the myocardium is mostly associated with abnormal
irritability and conductivity of the stimulus-transmitting system,
which initially manifests itself on ECG as longer P-R and Q-T
intervals, and, at higher degrees of deficiency, as tachycardia,
atrial fibrillation, premature ventricular contractions and as
ventricular fibrillation in extreme cases.On the other hand Mg
plays an important role in the regulation of blood concentration of
catecholamines, particularly epinephrine (E) and norepinephrine
(NE). Any deficiency of blood Mg concentration results in
hypercatecholaminemia followed by hypersensitization of the
myocardial cells.This problem is particularly relevant in patients
subjected to cardiosurgical procedures with ECC [6]. The complex
nature of such procedures, especially intraoperative normovolemic
haemodilution, may alter blood Mg levels, which is likely to result
in the dysfunction of various organs, particularly postoperatively
stunned myocardium.The aim of this study was to analyze the
influence of pre-operative magnesium supplementation on blood
epinephrine and norepinephrine concentrations in patients
undergoing surgical myocardial revascularization.
Patients and methods
The study was approved by the Bioethical Committee of Medical
University of Lublin (No KE-0254/244/2000) and included the
patients who underwent operations due to I° and II° coronary
disease (according to CCS). Exclusion criteria were: any
endocrinological, neurological or metabolic disease, myocardial
infarction in last 6 months before surgery and lack of patient’s
consent.
The patients underwent general anaesthesia with fentanyl,
midazolam and etomidat. Muscle relaxation was obtained by injecting
a single dose of pancuronium. The anaesthesia was maintained
throughout the procedure using midazolam-fentanyl infusion and
inhalatory fractionated doses of foran. During the implantation of
aorto-coronary bypasses the circulation and ventilation were
maintained by the heart-lung machine S III (Stockert). The
following substances were used for priming: Ringer’s solution,
6 % solution of hydroxyethylated starch (HAES), 20 %
mannitol, sodium hydroxycarbonate, and heparin. The same priming
was used for all patients (without Mg). Cardioplegia was prepared
using 0.9 % salt solution supplemented with 3g of potassium
chloride (Kalium chloratum, Polfa, Pl) and 20 mL of sodium
hydroxycarbonate.
The patients were randomly divided into 2 groups: A – the
patients receiving pre-operative Mg supplementation and B –
patients without pre-operative Mg supplementation. During the
surgery and in the early postoperative period (zero postoperative
day) all patients received potassium chloride 250 mg/h and Mg
sulfate 200 mg/h.
Immediately after surgery all patients were transferred to the
Postoperative Intensive Care Unit (PICU) where they received a
short-term infusion of 5 % glucose solution with insulin.
The blood specimens were obtained in 5 stages: 1) before
anesthesia after the radial artery cannulation, 2) during
normowolemic haemodilution and ECC, 3) immediately after surgery,
4) in the morning of the 1st postoperative day, 5) in
the morning of the 2nd postoperative day.
The blood samples were collected from the radial artery and
immediately centrifuged (25000 r/min., temp. 0°C); the obtained
serum was frozen at - 20°C. The Mg were determined by
spectrophotometric methods. The E and NE were measured by
radioimmunoassay methods.
The results were statistically analysed using Kruskall – Wallis
and Friedman test for initial detection of differences, and
Wilcoxon signed rank test, Mann-Whitney U and Spearman rank
correlation tests for interstage and intergroup comparisons. Since
data histograms showed skewed distributions nonparametric methods
of analysis were chosen.
Results
Forty men aged 50-72 (66.2 ± 7.5) were studied. Twenty-eight
patients had myocardial infarction during the past 3 years and
thirty five were treated due to concomitant arterial hypertension
(I° or II° according to WHO classification). None of the patients
was treated for endocrinological, neurological and other systemic
disease nor was resuscitated because of circulatory arrest. The
mean duration of the procedure was 189.2 min ± 32 and of
anaesthesia 205 min. ± 40.
In all the patients the aorta was typically clamped and the mean
closure time was 37.2 min. ± 12.5. The aorto-coronary
anastomosis was performed in mild hypothermia of 35.2 °C ± 0.4. In
all the cases weaning from the heart-lung machine was uneventful
and there was no need of intra-aortic contrapulsation.
The mean blood Mg concentration in group A before surgery was
1.03 mmol/L. The initiation of cardiopulmonary bypass caused a
decrease in blood Mg concentration that persisted throughout the
examination period ( (figure 1 ),
table 1)( Tableau 1 ). The same
changes were observed in group B, however Mg blood concentration in
stage 1 was 0.75 mmol/L ( (figure 2) ). There
were significant differences between these two groups in stages 1,
2 and 3 (table 1).
In group A, E increased from the stage 2 to 5 ( (figure 3) ) and
similar changes were noted in group B ( (figure 4) ). There
were significant differences between group A and B in stage 3
(table 1).
The NE level increased in both groups (figures 5 and 6),
but higher blood concentrations were observed in group B
(table 1). There were significant differences between group A
and B in stage 2.
The Spearman correlation showed a significant relationship
between Mg in stage 1 and E in stage 2, Mg and NE in stages 4 and 5
in group A. In group B significant relationship between Mg in stage
3 and E in stage 4, Mg and NE in stages 2 and 3 were observed
(table 2)( Tableau 2 ).
Tableau 1 Magnesium, epinephrine and norepinephrine
values in each stage.
|
Intergroup relationships – the comparison with first
stage
|
|
Stages
|
1
|
2
|
3
|
4
|
5
|
|
Mg - group A
|
median
|
0.99
|
0.87***
|
0.89*
|
0.96***
|
0.98**
|
|
quartile 1
|
0.97
|
0.72
|
0.79
|
0.81
|
0.95
|
|
quartile 3
|
1.09
|
0.98
|
0.99
|
0.99
|
1
|
|
Mg – group B
|
median
|
0.78
|
0.59***
|
0.69*
|
0.90***
|
0.93**
|
|
quartile 1
|
0.70
|
0.48
|
0.64
|
0.79
|
0.73
|
|
quartile 3
|
0.79
|
0.68
|
0.75
|
0.99
|
0.99
|
|
E – group A
|
median
|
0.06
|
0.10**
|
0.09*
|
0.08*
|
0.08*
|
|
quartile 1
|
0.03
|
0.06
|
0.06
|
0.06
|
0.06
|
|
quartile 3
|
0.09
|
0.16
|
0.12
|
0.12
|
0.12
|
|
E – group B
|
median
|
0.06
|
0.12***
|
0.16***
|
0.09***
|
0.09***
|
|
quartile 1
|
0.04
|
0.09
|
0.10
|
0.07
|
0.08
|
|
quartile 3
|
0.07
|
0.20
|
0.20
|
0.11
|
0.12
|
|
NE – group A
|
median
|
0.08
|
0.09***
|
0.16***
|
0.22***
|
0.11*
|
|
quartile 1
|
0.06
|
0.08
|
0.11
|
0.12
|
0.07
|
|
quartile 3
|
0.11
|
0.21
|
0.35
|
0.74
|
0.24
|
|
NE – group B
|
median
|
0.11
|
0.24***
|
0.25***
|
0.24**
|
0.14*
|
|
quartile 1
|
0.09
|
0.16
|
0.16
|
0.13
|
0.09
|
|
quartile 3
|
0.18
|
0.37
|
0.60
|
0.97
|
0.79
|
|
The relationships between group A and B (Mann-Whitney U test)
|
|
Mg
|
A:B
|
p < 0.001
|
p < 0.001
|
p < 0.01
|
-
|
-
|
|
E
|
A:B
|
-
|
-
|
p < 0.01
|
-
|
-
|
|
NE
|
A:B
|
-
|
p < 0.01
|
-
|
-
|
-
|
Tableau 2 The Spearman correlation test.
|
N
|
R
|
|
|
|
Stages
|
Patients
|
Spearman
|
t(N-2)
|
p
|
|
Group A: magnesium and epinephrine
|
|
01:02
|
20
|
-0.54145
|
-2.73233
|
0.013678
|
|
Group A:magnesium and norepinephrine
|
|
02:02
|
20
|
-0.58503
|
-3.06043
|
0.006737
|
|
04:04
|
20
|
-0.54593
|
-2.76453
|
0.01277
|
|
04:05
|
20
|
-0.59774
|
-3.16332
|
0.005379
|
|
05:05
|
20
|
0.676971
|
3.902316
|
0.001044
|
|
Group B: magnesium and epinephrine
|
|
03:04
|
20
|
0.459744
|
2.196416
|
0.041403
|
|
Group B: magnesium and norepinephrine
|
|
02:02
|
20
|
-0.78947
|
-5.45705
|
3.49E-05
|
|
02:03
|
20
|
-0.69925
|
-4.14987
|
0.000602
|
|
02:05
|
20
|
-0.48815
|
-2.37301
|
0.028986
|
|
03:03
|
20
|
-0.57293
|
-2.96576
|
0.008279
|
Discussion
The effects of preoperative supplementation of Mg on its intra- and
postoperative blood levels during ECC have not been explicitly
documented in the literature. The lack of data on the advantages of
such management in patients undergoing ECC procedures seems to
point out the significance of observations undertaken. The complex
character of ECC procedures as well as intra- and postoperative
treatment used may significantly disturb the hormonal and
electrolyte balance, although the relation between the E and NE
concentration in blood and the Mg level is known and well
documented in the literature [6-11]. Many researchers stress the
strict correlation between the blood Mg and NE concentrations and
myocardial insufficiency [10, 12]. This correlation was confirmed
by Samejim et al. [10], who in their study on interrelations
between concentrations of Mg and NE in the blood and myocardial
insufficiency demonstrated the reverse relationship between the
above-mentioned factors. According to Banfi et al. [13], the
development of myocardial insufficiency is strictly connected to
the activation of the neurohormonal system, and the production and
release of NE, in particular. A drop in stroke volume and decrease
in myocardial contraction cause an increase in the metalloprotein 2
level, leading to the accumulation of the above-mentioned
substances in fibroblasts. Increased concentrations of these
substances significantly limit the diastole of the myocardium
contributing to further impairment of its function. Therefore many
researchers believe that the blood NE concentration is a relevant
diagnostic factor of myocardial insufficiency [9, 14, 15]. However,
it is difficult to determine explicitly whether high levels of the
hormone in question observed in our study caused myocardial
insufficiency. Nevertheless, it is worth stressing that high NE
levels were accompanied by a significant drop in blood Mg
concentrations, which may confirm their relations as mentioned
above.
Moreover, the “inotropically positive” action of Mg on the
myocardium seems interesting and worth discussing. The Mg
substitution-induced increased index of the left ventricle work
[16] may result from the inhibitory effects of the element analyzed
on the intracardiac secretion of NE [9] as well as from the
inhibition of N type calcium receptors [17]. Significantly higher
Mg levels were observed in our study in the group of patients
receiving preoperative Mg supplementation and less frequent use of
inotropically positive agents in this group seem to confirm the
favourable effects of Mg on the myocardium, however, further
observations are required to determine these relations explicitly.
It should be also emphasized that preoperative supplementation of
Mg deficiency may produce beneficial effects already before the
initiation of the procedure discussed, since it is well known that
high blood levels of this element reduce the reactivity of adrenals
and nerve endings, which leads to easier stabilization of the
circulatory system. Studying the blood E and NE concentrations in
pigs receiving Mg preparations and standard diet before slaughter,
D’Souza et al. [18] noted significantly lower NE values in animals
with high blood Mg levels. A significantly higher content of muscle
glycogen observed by the above authors in this group of animals and
lower levels of muscle lactates at higher pH of the muscle cells
should also be stressed. This fact seems to be extremely important
in cardiosurgical patients, although precise cellular changes in
such patients are unknown and their determination requires
additional studies.
Preoperative supplementation of magnesium also has favourable
effects on the adrenergic response of the organism during the
procedure of endotracheal intubation. The increased blood
concentrations of catecholamines observed during intubation [19-23]
are dangerous, particularly in cardiac patients. This is confirmed
by Puri et al. [24] who in their studies on haemodynamic disorders
during intubation of patients undergoing surgical revascularization
of the myocardium observed an increase in the stroke volume index
without ST changes in patients receiving Mg infusions compared to
the group without such infusions, in whom increased work of the
myocardium was associated with significant EKG changes. Moreover, a
smaller increase in mean arterial pressure and systemic vascular
resistance in response to intubation is worth noticing. For these
reasons the researchers conclude that Mg infusions have more
beneficial effects stabilizing the cardiovascular system than
lidocaine. Dube and Granry [2] also emphasize that preoperative Mg
supplementation before induction of anaesthesia stabilizes the
cardiovascular system and facilitates the control of the adrenergic
response to intubation. The lower blood NE levels observed in our
study in patients receiving Mg are in agreement with the data
quoted, however the effects of high concentrations of this element
on the haemodynamic changes during intubation require further
observation. Nevertheless, it is worth stressing that in the group
of patients receiving Mg, the initial (stage 1) concentration of NE
was already lower, although the difference was not statistically
significant. Therefore it may be assumed that preoperative Mg
supplementation favourably affects the adrenergic response to
intubation in patients undergoing surgical revascularization of the
myocardium and should be the treatment of choice in such cases.
While analysing the effects of Mg supplementation, the
antiarrhythmogenic action of this element should be stressed,
particularly in the post-infusion period. Many researchers
emphasize the dangers associated with hypomagnesemia in patients
after ECC procedures [25-27]. This fact is likely to result from
hypokaliemia accompanying low Mg levels [28, 29]. According to
Whang and Ryder [28], low levels of potassium are related to blood
Mg deficiencies in 61 % of cases and therefore potassium
supplementation should be connected with Mg supply. According to
Treggiari et al. [30], on the other hand, postoperative Mg
substitution is ineffective for reducing artial fibrillation
episodes, although low levels of the element in question predispose
this pathology.
Another factor, which may induce perioperative arrhythmias, is
likely to be a decrease in the myocardial arrhythmogenic threshold
for E mentioned earlier [31]. It should be stressed that the high
levels of E observed in our study in the postoperative period may
favour arrhythmias in cases of hypomagnesemia, however, precise
determination of these relations requires additional
observation.
Furthermore, the analgesic effects of Mg seem interesting and
important. In the recent years controversy has arisen and numerous
clinical studies have been devoted to it [32-34]. It is thought
that Mg has inhibitory effects (through affecting the calcium
channels) on the brain’s NMDA receptors. According to Tramer et al.
[34] and Telci et al. [35], this antagonistic action may limit the
induction of the central sensitization by reducing the sensitivity
of the peripheral receptors nociceptive to pain. For these reasons
the patients receiving Mg require less morphine, less frequently
complain of postoperative discomfort and sleep disorders, occurring
in the first 48 hours after the administration of first doses of
morphine. Similar advantages of Mg administration were demonstrated
by Koining et al. [36]. They found the preoperative supply of this
element significantly reduces the need for analgesics both during
the surgical procedure and in the immediate postoperative period.
Kara et al. [32] observed lower intra- and postoperative use of
fentanyl and morphine in patients who received Mg during
hysterectomy. Therefore it may seem that this element has definite
analgesic effects. However, such effects of Mg are inconsistent
with the observations by Ko et al. [33] who studied the Mg changes
in the cerebro-spinal fluid during hysterectomy and found no
significant Mg changes, although a difference in concentrations of
this element was demonstrated in blood serum. The negative relation
between the need for analgesics and Mg concentration in the
cerebro-spinal fluid is also worth stressing. It should be also
added that hysterectomy procedures are not the most painful ones,
which might have affected the findings.
It is also difficult to determine the Mg analgesic activity in
our cases as the procedures of surgical revascularization using the
transsternal approach belong to the most stressful operations.
Therefore, all the patients are administered high doses of
analgesics in the postoperative period; moreover, combined
anaesthesia (epidural and general) is used more and more
commonly.
Discussing the effects of preoperative Mg substitution on
homeostasis in ECC its beneficial effects on the intensification of
postoperative apoptotic processes should also be emphasized as
hypomagnesemia favours intensified processes of cell
self-destruction. The main damaging mechanisms are thought to be
disorders of the energetic balance of the cell resulting from low
levels of this element [37-39] and effects of high blood
concentrations of catecholamines, NE in particular [7]. The
observed hypomagnesemia-induced dysfunction of the sodium-potassium
pump and ATPase results in a decrease in intracellular potassium
and elevation in calcium, which is likely to substantially limit
the adaptative ability of the cell, particularly in stress
situations. Such disorders also lead to reduced transmembranous
potential in the mitochondria [37] causing the cell oedema. This is
confirmed by the observations by Marcoccie et al. [37] who examined
the causes of disorders of the transmembranous mitochondrial
potential and observed low intracellular levels of Mg accompanied
by the accumulation of calcium ions. It is difficult, however, to
determine explicitly the direct effects of Mg substitution on the
intensification of apoptosis of cells; nevertheless the recent
reports increasingly stress the influence of extracorporeal
circulation procedures on the process of their self-destruction
[40]. Therefore, perioperative Mg substitution may seem right
although further studies are required to determine its precise
effects on apoptotic processes.
Conclusion
1) CABG with normovolemic haemodilution causes a decrease in blood
magnesium concentration and an increase in blood adrenaline and
norepinephrine concentrations.
2) Preoperative, oral supplementation of magnesium substantially
reduces intra- and postoperative disorders of blood magnesium
concentrations and significantly attenuates adrenergic response to
operative stress.
References
1 Booth JV, Phillips-Bute B, McCants CB,
Podgoreanu MV, Smith PK, Mathew PJ, Newman MF.
Low serum magnesium level predicts major adverse cardiac events
after coronary artery bypass graft surgery. Am Heart J 2003; 145:
1108-13.
2 Dube L, Granry JC. The therapeutic use of magnesium
in anesthesiology, intensive care and emergency medicine: a review.
Can J Anesth 2003; 50: 732-46.
3 Haigney MCP, Silver B, Tanglao E,
Silverman HS, Shapiro E, Gerstenblith G,
Schulman SP. Non-invasive measurement of tissue magnesium and
correlation with cardiac levels. Circulation 1995; 92: 2190-7.
4 Agus ZS. Hypomagnesemia. J Am Soc Nephrol 1999; 10:
1616-22.
5 Nair RR, Nair P. Alteration of myocardial mechanics
in marginal magnesium deficiency. Magnes Res 2002; 15: 287-306.
6 Polderman KH, Girbes ARJ. Severe electrolyte
disorders following cardiac surgery: a prospective controlled
observational study. Crit Care 2004; 8: R459-R466.
7 Delva P, Pastori C, Degan M, Montesi G,
Lechi A. Catecholamine induced regulation in vitro and ex vivo
of intralymphocyte ionized magnesium. J Membr Biol 2004; 199:
163-71.
8 Malara A, Corsonello A, Buemi M, De
Domenico D, Ientile R, Corica F. Effects of alpha-
and beta-adrenergic stimulation on free magnesium concentrations in
platelets from healthy and obese individuals. Magnes Res 2001; 14:
263-72.
9 Ohtsuka S, Oyake Y, Seo Y, Eda K,
Yamaguchi I. Magnesium sulphate infusion suppresses the
cardiac release of noradrenaline during a handgrip stress test. Can
J Cardiol 2002; 18: 133-40.
10 Samejima H, Tanabe K, Suzuki N, Omiya K,
Marayama M. Magnesium dynamics and sympathetic nervous system
activity in patients with chronic heart failure. Jpn Circ J 1999;
63: 267-73.
11 Sameshima H, Tanaka S, Kamitomo M,
Ikenoue T, Sakamoto H. Magnesium sulfate and fetal plasma
concentrations of epinephrine, norepinephrine and vasopressin in
response to acute hypoxemia in goats. J Soc Gynecol Investig 2000;
7: 328-32.
12 Brunner-La Rocca HP, Esler MD, Jennings GL,
Kaye DM. Effest of cardiac sympathetic nervous activity on
mode of death in congestive heart failure. Eur Heart J 2001; 22:
1136-43.
13 Banfi C, Cavalca V, Veglia F, Brioschi M,
Barcella S, Mussoni L, Boccotti L, Tremoli E,
Biglioli P, Agostini P. Neurohormonal activation is
associated with increased levels of plasma matrix
metalloproteinase-2 in human heart failure. Eur Heart J 2005; 26:
481-8.
14 Benedictn CR, Shelton B, Johnstone DE,
Francis G, Greenberg B, Konstam M,
Probstfield JL, Yusuf S. Prognostic significance of
plasma norepinephrine in patients with asymptomatic left
ventricular dysfunction. Circulation 1996; 94: 690-7.
15 Rundqvist B, Elam M, Bergmann-Sverrisdotir Y,
Eisenhofer G, Friberg P. Increased cardiac adrenergic
drive precedes generalized sympathetic activation in human heart
failure. Circulation 1997; 95: 169-75.
16 Caspi J, Rudis E, Bar I, Safadi T,
Saute M. Effects of magnesium on myocardial function after
coronary artery bypass grafting. Ann Thorac Surg 1995; 59:
942-7.
17 Shimosawa T, Takano K, Ando K, Fujita T.
Magnesium inhibits norepinephrine release by blocking N-type
calcium channels at peripheral sympathetic nerve endings.
Hypertension 2004; 44: 897-902.
18 D’Souza DN, Warner RD, Leury BJ,
Dumshea FR. The effect of dietary magnesium asparate
supplementation on pork quality. J Anim Sci 1998; 76: 104-9.
19 Baumgartner H, Sparr H, Ladner E,
Haisjackl M. Catechlamine response to laryngoscopy and
intubation: on the importance of sampling site. Anaesthesia 1993;
48: 359.
20 Brandt MR, Korshin J, Hansen PA,
Hummer L, Madsen SN, Rygg I, Kehler H.
Influence of morphine anaesthesia on the endocrine-metabolic
response to open heart surgery. Acta Anaesth Scand 1978; 22:
400-12.
21 Crozier TA, Drobnik L, Stafforst D,
Ketter D. Opiate modulation of the stress-induced increase of
vasoactive intestinal peptide (VIP) in plasma. Horm Metab Res 1988;
20: 352-6.
22 Oczenski W, Krenn H, Dahaba AA, Binder M,
El-Schhawi-Kienzl I, Jellinek H, Schwarz S,
Fitzgerald RD. Hemodynamic and catecholamine stress responses
to insertion of the Combitube, laryngeal mask airway or tracheal
intubation. Anesth Analg 1999; 88: 1389-94.
23 Walsh ES, Peterson JL, O’Riordan JB,
Hall GM. Effects of high-dose fentanyl anaesthesia on
metabolic and endocrine response to cardiac surgery. Br J Anaesth
1981; 53: 1155.
24 Puri GD, Marudhachalm KS, Chari P,
Suri RK. The effect of magnesium sulfate on hemodynamics and
its efficacy in attenuating the response to endotracheal intubation
in patients with coronary artery disease. Anesth Analg 1998; 87:
808-11.
25 Toraman F, Karabulut EH, Alban HC,
Dagden S, Tarcan S. Magnesium infusion dramatically
decreases the incidence of atrial fibrillation after coronary
artery bypass grafting. Ann Thorac Surg 2001; 72: 1256-61.
26 Zaman AG, Alagmir F, Richens T,
Williams R, Rothman MT, Mills PG. The role of signal
averaged P wave duration and serum magnesium as a combined
predictor of atrial fibrillation after elective coronary artery
bypass surgery. Heart 1997; 77: 527-31.
27 Yeatman M, Caputo M, Narayan P, Lotto AA,
Ascione R, Bryan AJ, Angelini GD. Magnesium
supplemented warm blood cardioplegia in patients undergoing
coronary artery revascularization. Ann Thorac Surg 2002; 73:
112-8.
28 Whang R, Ryder KW. Frequency of hypomagnesemia and
hypermagnesemia. Requested versus routine. JAMA 1990; 263:
3063-4.
29 Whang R, Whang DD, Ryan MP. Refractory
potassium repletion. A consequence of magnesium deficiency. Arch
Intern Med 1992; 152: 40-5.
30 Treggiari-Venzi MM, Waeber JL, Perneger TV,
Suter PM, Adamec R, Romand JA. Intravenous
amiodarone or magnesium sulphate is not cost-beneficial prophylaxis
for atrial fibrillation after coronary artery bypass surgery. Br J
Anaesth 2000; 85: 690-5.
31 Crawford MW, Ho DS, Shams M, Gow R.
Magnesium deficiency alters the threshold for epinephrine-induced
arrythmias during halotane or sevoflurane anesthesia in rat. J
Cardithorac Vasc Anesth 2004; 18: 313-6.
32 Kara H, Sahin N, Ulusan V, Aydogdu T.
Magnesium infusion reduces perioperative pain. Eur J Anaesthesiol
2002; 19: 52-6.
33 Ko SH, Lim HR, Kim DC, Han YJ,
Choe H, Song HS. Magnesium sulfate does not reduce
postoperative analgesic requirements. Anesthesiology 2001; 95:
640-6.
34 Tramer MR, Schneider J, Marti RA,
Rifat K. Role of magnesium sulfate in postoperative analgesia.
Anesthesiology 1996; 84: 340-7.
35 Telci L, Esen F, Akcora D, Erden T,
Canbolat AT, Akpir K. Evaluation of effects of magnesium
sulphate in reducing intraoperative anaesthetic requirements. Br J
Anaesth 2002; 89: 594-8.
36 Koining H, Wallner T, Marhofer P,
Andel H, Hörauf K, Mayer N. Magnesium sulfate
reduces intra and postoperative analgesic requirements. Anesth
Analg 1998; 87: 206-10.
37 Marcocci L, Marchi U, Salvi M,
Milella ZG, Nocera S, Agostinelli E, Mondovi B,
Toninello A. Tyramine and monoamine oxidase inhibitors as
modulators of the mitochondrial membrane permeability transition. J
Membr Biol 2002; 188: 23-31.
38 Rock E, Gueux E, Cubizolles C,
Rayssiguier Y. Calcium permeability and ATPase activites of
red blood cells of magnesium deficient rats. J Nutr Biochem 1995;
5: 351-5.
39 Lang F, Gulbins E, Szabo I,
Leppe-Wienhues A, Huber SM, Duranton C,
Lang KS, Lang PA, Wieder T. Cell volume and the
regulation of apoptotic cell death. J Mol Recognit 2004; 17:
473-80.
40 Korycińska A, Dąbrowski W, Dragan M,
Pożarowski P, Biernacka J, Stążka J,
Roliński J. The degree of lymphocytic apoptosis during
coronary artery bypass graft procedure and normovolemic
haemodilution. Pol J Environ Stu 2005; 14: 223-7.
|